The role of PTEN tumor suppressor pathway staining in carcinoma in situ of the bladder

John P. Sfakianos, Lan Lin Gellert, Alexandra Maschino, Geoffrey T. Gotto, Philip H. Kim, Hikmat Al-Ahmadie, Bernard H. Bochner

Research output: Contribution to journalArticle

Abstract

Objectives: The PI3k/Akt pathway has been associated with the development and progression of bladder tumors, with most studies focused on papillary or muscle-invasive tumors. We sought to characterize the expression patterns of the PI3K/Akt pathway in a large cohort of high-risk preinvasive carcinoma in situ (CIS) tumors of the bladder. Our goal was to understand whether PI3K/Akt pathway alterations associated with CIS resemble early- or late-stage bladder cancers. Material and methods: We evaluated tissue specimens from 97 patients with CIS of the bladder, of which 14 had a concomitant papillary tumor. All patients were treated with intravesical bacillus Calmette-Guerin. All specimens were evaluated for PTEN, p-AKT, and p-S6 immunoreactivity. Markers were evaluated for percentage and intensity of staining and were scored using a 0 to 3+grading system. Results: PTEN staining was noted as least intense in 67% of tumor specimens and 22% of normal urothelium. P-Akt and p-S6 had intense staining in 77% and 90% of tumor specimens vs. 44% and 68% in normal tissue, respectively. Low-intensity staining for PTEN at 12 months correlated with higher recurrence risk (P = 0.026). Conclusion: We describe a large cohort of CIS bladder tumors with decreased staining intensity of PTEN and increased staining intensity of p-AKT and p-S6, similar to high-grade and high-stage papillary tumors. Low-intensity staining of PTEN at 12 months was associated with an increased risk of recurrence.

Original languageEnglish (US)
Pages (from-to)657-662
Number of pages6
JournalUrologic Oncology: Seminars and Original Investigations
Volume32
Issue number5
DOIs
StatePublished - 2014
Externally publishedYes

Fingerprint

Carcinoma in Situ
Urinary Bladder
Staining and Labeling
S 6
Urinary Bladder Neoplasms
Neoplasms
Phosphatidylinositol 3-Kinases
Recurrence
Urothelium
Papillary Muscles
Mycobacterium bovis

Keywords

  • Bladder cancer
  • Carcinoma in situ
  • PTEN

ASJC Scopus subject areas

  • Oncology
  • Urology
  • Medicine(all)

Cite this

Sfakianos, J. P., Lin Gellert, L., Maschino, A., Gotto, G. T., Kim, P. H., Al-Ahmadie, H., & Bochner, B. H. (2014). The role of PTEN tumor suppressor pathway staining in carcinoma in situ of the bladder. Urologic Oncology: Seminars and Original Investigations, 32(5), 657-662. https://doi.org/10.1016/j.urolonc.2014.02.003

The role of PTEN tumor suppressor pathway staining in carcinoma in situ of the bladder. / Sfakianos, John P.; Lin Gellert, Lan; Maschino, Alexandra; Gotto, Geoffrey T.; Kim, Philip H.; Al-Ahmadie, Hikmat; Bochner, Bernard H.

In: Urologic Oncology: Seminars and Original Investigations, Vol. 32, No. 5, 2014, p. 657-662.

Research output: Contribution to journalArticle

Sfakianos, JP, Lin Gellert, L, Maschino, A, Gotto, GT, Kim, PH, Al-Ahmadie, H & Bochner, BH 2014, 'The role of PTEN tumor suppressor pathway staining in carcinoma in situ of the bladder', Urologic Oncology: Seminars and Original Investigations, vol. 32, no. 5, pp. 657-662. https://doi.org/10.1016/j.urolonc.2014.02.003
Sfakianos, John P. ; Lin Gellert, Lan ; Maschino, Alexandra ; Gotto, Geoffrey T. ; Kim, Philip H. ; Al-Ahmadie, Hikmat ; Bochner, Bernard H. / The role of PTEN tumor suppressor pathway staining in carcinoma in situ of the bladder. In: Urologic Oncology: Seminars and Original Investigations. 2014 ; Vol. 32, No. 5. pp. 657-662.
@article{15f096959ab742fe9946bfb6e61ac704,
title = "The role of PTEN tumor suppressor pathway staining in carcinoma in situ of the bladder",
abstract = "Objectives: The PI3k/Akt pathway has been associated with the development and progression of bladder tumors, with most studies focused on papillary or muscle-invasive tumors. We sought to characterize the expression patterns of the PI3K/Akt pathway in a large cohort of high-risk preinvasive carcinoma in situ (CIS) tumors of the bladder. Our goal was to understand whether PI3K/Akt pathway alterations associated with CIS resemble early- or late-stage bladder cancers. Material and methods: We evaluated tissue specimens from 97 patients with CIS of the bladder, of which 14 had a concomitant papillary tumor. All patients were treated with intravesical bacillus Calmette-Guerin. All specimens were evaluated for PTEN, p-AKT, and p-S6 immunoreactivity. Markers were evaluated for percentage and intensity of staining and were scored using a 0 to 3+grading system. Results: PTEN staining was noted as least intense in 67{\%} of tumor specimens and 22{\%} of normal urothelium. P-Akt and p-S6 had intense staining in 77{\%} and 90{\%} of tumor specimens vs. 44{\%} and 68{\%} in normal tissue, respectively. Low-intensity staining for PTEN at 12 months correlated with higher recurrence risk (P = 0.026). Conclusion: We describe a large cohort of CIS bladder tumors with decreased staining intensity of PTEN and increased staining intensity of p-AKT and p-S6, similar to high-grade and high-stage papillary tumors. Low-intensity staining of PTEN at 12 months was associated with an increased risk of recurrence.",
keywords = "Bladder cancer, Carcinoma in situ, PTEN",
author = "Sfakianos, {John P.} and {Lin Gellert}, Lan and Alexandra Maschino and Gotto, {Geoffrey T.} and Kim, {Philip H.} and Hikmat Al-Ahmadie and Bochner, {Bernard H.}",
year = "2014",
doi = "10.1016/j.urolonc.2014.02.003",
language = "English (US)",
volume = "32",
pages = "657--662",
journal = "Urologic Oncology",
issn = "1078-1439",
publisher = "Elsevier Inc.",
number = "5",

}

TY - JOUR

T1 - The role of PTEN tumor suppressor pathway staining in carcinoma in situ of the bladder

AU - Sfakianos, John P.

AU - Lin Gellert, Lan

AU - Maschino, Alexandra

AU - Gotto, Geoffrey T.

AU - Kim, Philip H.

AU - Al-Ahmadie, Hikmat

AU - Bochner, Bernard H.

PY - 2014

Y1 - 2014

N2 - Objectives: The PI3k/Akt pathway has been associated with the development and progression of bladder tumors, with most studies focused on papillary or muscle-invasive tumors. We sought to characterize the expression patterns of the PI3K/Akt pathway in a large cohort of high-risk preinvasive carcinoma in situ (CIS) tumors of the bladder. Our goal was to understand whether PI3K/Akt pathway alterations associated with CIS resemble early- or late-stage bladder cancers. Material and methods: We evaluated tissue specimens from 97 patients with CIS of the bladder, of which 14 had a concomitant papillary tumor. All patients were treated with intravesical bacillus Calmette-Guerin. All specimens were evaluated for PTEN, p-AKT, and p-S6 immunoreactivity. Markers were evaluated for percentage and intensity of staining and were scored using a 0 to 3+grading system. Results: PTEN staining was noted as least intense in 67% of tumor specimens and 22% of normal urothelium. P-Akt and p-S6 had intense staining in 77% and 90% of tumor specimens vs. 44% and 68% in normal tissue, respectively. Low-intensity staining for PTEN at 12 months correlated with higher recurrence risk (P = 0.026). Conclusion: We describe a large cohort of CIS bladder tumors with decreased staining intensity of PTEN and increased staining intensity of p-AKT and p-S6, similar to high-grade and high-stage papillary tumors. Low-intensity staining of PTEN at 12 months was associated with an increased risk of recurrence.

AB - Objectives: The PI3k/Akt pathway has been associated with the development and progression of bladder tumors, with most studies focused on papillary or muscle-invasive tumors. We sought to characterize the expression patterns of the PI3K/Akt pathway in a large cohort of high-risk preinvasive carcinoma in situ (CIS) tumors of the bladder. Our goal was to understand whether PI3K/Akt pathway alterations associated with CIS resemble early- or late-stage bladder cancers. Material and methods: We evaluated tissue specimens from 97 patients with CIS of the bladder, of which 14 had a concomitant papillary tumor. All patients were treated with intravesical bacillus Calmette-Guerin. All specimens were evaluated for PTEN, p-AKT, and p-S6 immunoreactivity. Markers were evaluated for percentage and intensity of staining and were scored using a 0 to 3+grading system. Results: PTEN staining was noted as least intense in 67% of tumor specimens and 22% of normal urothelium. P-Akt and p-S6 had intense staining in 77% and 90% of tumor specimens vs. 44% and 68% in normal tissue, respectively. Low-intensity staining for PTEN at 12 months correlated with higher recurrence risk (P = 0.026). Conclusion: We describe a large cohort of CIS bladder tumors with decreased staining intensity of PTEN and increased staining intensity of p-AKT and p-S6, similar to high-grade and high-stage papillary tumors. Low-intensity staining of PTEN at 12 months was associated with an increased risk of recurrence.

KW - Bladder cancer

KW - Carcinoma in situ

KW - PTEN

UR - http://www.scopus.com/inward/record.url?scp=84902532799&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84902532799&partnerID=8YFLogxK

U2 - 10.1016/j.urolonc.2014.02.003

DO - 10.1016/j.urolonc.2014.02.003

M3 - Article

C2 - 24840867

AN - SCOPUS:84902532799

VL - 32

SP - 657

EP - 662

JO - Urologic Oncology

JF - Urologic Oncology

SN - 1078-1439

IS - 5

ER -